Saka Farma Laboratories is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Dki Jakarta. The company was founded in 1997. Saka Farma Laboratories is a prominent player in the Indonesian pharmaceutical industry, known for its commitment to quality and innovation in healthcare solutions. The company was founded by a group of visionary entrepreneurs who aimed to address the growing healthcare needs in Indonesia. Saka Farma specializes in the production of over-the-counter (OTC) medications, prescription drugs, and health supplements. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. Saka Farma's product portfolio includes a wide range of pharmaceuticals, such as analgesics, antibiotics, and vitamins, with popular brands like Mixagrip and Bodrex leading the market. In addition to its domestic operations, Saka Farma has expanded its reach to several countries in Southeast Asia, establishing a modest but growing international footprint. The company collaborates with various local and international partners to enhance its research and development capabilities and to bring innovative healthcare solutions to the market. Saka Farma is a member of several pharmaceutical and healthcare associations, actively participating in industry forums to stay at the forefront of medical advancements. The company is committed to sustainable practices and aims to improve public health through its high-quality products and services. With a vision to become a leading pharmaceutical company in the region, Saka Farma Laboratories continues to invest in cutting-edge technology and research to meet the evolving needs of its customers and contribute to the overall well-being of society.
Headquarters
RT 009 RW 011
North Jakarta; Jakarta;
Postal Code: 14360
Contact Details: Purchase the PT Saka Farma Laboratories report to view the information.
Website: http://www.kalbeconsumerhealth.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service